Life Science Integrates is delighted to announce the 11th Pharma Integrates conference. This year the event returns to an in-person event, being held at the Leonardo Royal Hotel, London Tower Bridge.
This year Pharma Integrates will focus on pharma and healthcare senior leadership. Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
This one-day gathering of technology, diagnostics, devices and therapeutics organisations, as well as clinicians and regulators, provides a platform to discuss the major challenges impacting the pharmaceutical sector.
Pharma Integrates 2022 provides an opportunity to engage with top executives in the pharmaceutical sector, diagnostics, manufacturing, supply chain, funding and investment.
This year the three sectors covered by the event will be:
· Big Health Issues - How do we tackle some of the biggest health challenges, such as chronic conditions, respiratory, cancer and antimicrobial resistance?
· Technology - How can we use technology to improve health outcomes, improve sustainability and create robust supply chains?
· Enablers - How do we enable a better Industry, through creating diverse skilled teams, empowering the patient and navigating the economic and regulatory environment?
For more information and to view our agenda please click the link below https://www.lifescienceintegrates.com/agenda/pharma-integrates-2022/
As SBC is a partner of Pharma Integrates 2022, we have a number of passes available for you to attend.
If you are a supplier to the life science industry (e.g. professional services, CMDOs, CROs, etc.) you can access a 25% discount by clicking here and using promo code PI22SBC25.
We are able to offer complimentary passes to everyone else that would like to attend. To register please click here and use promo code PI22SBC100.
Please note registration closes at 17:00 on 7th November 2022.